®
About Us
Founded in 2014, BLD Pharmatech Ltd. is a leading supplier and manufacturer of research chemicals to pharmaceutical companies, universities, biotech companies,healthcare industries,contract research organizations etc.
With its own R&D center in Shanghai, BLD Pharmatech Ltd. main field of expertise covers the development and production of heterocycles,boronic acids, amino acids, metal catalysts and chiral compounds.
Qualifications
BD22691[80745-09-1]Cyclohexanamine N2-((benzyloxy)carbonyl)-Nw-((4-methoxy-2,3,6-trimethylphenyl)sulfonyl)-L-argininate*
Specific Information
| Purity : | 98% | Specific Rotation : | |
| NMR(H/C/F/S/P) : | E.E. : | ||
| HPLC : | Water Content : | ||
| Polymerization Inhibitor : | Single Impurity : | ||
| Melting Point : | Density : | ||
| Packaging : | Solubility : | ||
| Name Note : | Acetic Acid : | ||
| Beilstein : | Grade : | ||
| Specific Gravity : | Viscosity : | ||
| Others : | |||
Product Details
| Cat No. : | BD22691 | Synonyms : | Cyclohexanamine N2-((benzyloxy)carbonyl)-Nw-((4-methoxy-2,3,6-trimethylphenyl)sulfonyl)-L-argininate |
| CAS No. : | 80745-09-1 | MDL NO : | MFCD00057997 |
| Formule : | C30H45N5O7S | InChI Key : | N/A |
| M.W : | 619.77 | Pubchem ID : | 13385652 |
| Boiling Point : | No data available | ||
Safety
| Signal Word : | Warning | Class : | |
| Precautionary Statements : | P261-P305+P351+P338 | UN# : | |
| Hazard Statements : | H302-H315-H319-H335 | Packing Group : | |
| GHS Pictogram: | |||
R&D Center
- +CONTACT
TM
Copyright © 2013-2024 BLDpharm. All Rights Reserved.
Research Use Only!